Werken bij Siemens HealthineersPersInvestor Relations
  1. Home
  2. Clinical Fields
  3. Oncology
  4. Cancer types
  5. Lung Cancer
Lung Cancer

Lung Cancer

Targeting lung cancer

A profound understanding of the facetted characteristics and behavior of a tumor demands deep and integrated knowledge among clinical experts collaborating in interdisciplinary teams – a joint effort to empower personalized cancer care. By strategically combining advanced imaging, IT, and laboratory applications as well as therapy, lung cancer management can be improved along the patient pathway. Explore our holistic portfolio for lung cancer and discover how our advanced solutions support you every step of the pathway – from screening to follow-up.

  1. Screening

    Explore our portfolio of ultra-low-dose CT scanners and AI tools that support you in your diagnostic assessments of lung cancer nodules during screening.

​Screening


Detecting early-stage lung cancer with low-dose CT scanning can dramatically improve the long-term survival rate of lung cancer patients. A study4 shows that patients diagnosed with lung cancer by low-dose CT screening have a 20-year survival rate of 81%. If diagnosed in the earliest Stage I and if adequate therapy has been applied, long-term survival was 95%. This emphasizes the benefit to establish screening programs for earlier detection. Our ultra-low-dose CT scanners and AI tools help you deliver confident and accurate screening outcomes.

Low-dose CT scanners for lung cancer screening

Ultra-low-dose CT scanners

Our CT scanners come with advanced technology inside that allows ultra-low-dose, non-contrast chest CT scans for a screening examination.

Lung cancer workflow powered by AI solutions

Smart AI tools

A smart augmented reading aid and AI-powered workflow solution help reduce repetitive tasks and supports diagnostic precision by detecting and highlighting possible nodules.

Diagnosis & staging

Confident diagnosis and accurate staging of lung cancer are essential for adequate therapy selection, precise treatment planning – and ultimately key for therapy success. Obtain highly detailed images, perform targeted biopsies, and share data seamlessly between departments – with our comprehensive portfolio of advanced imaging, biopsy, and software solutions.

1/8
Imaging03
Biopsy & staging03
Software02
Lung cancer imaging with ultra-low-dose CT scanners


Interventional CT procedure to biopsy a lung cancer lesion

CT

Our ultra-low-dose CT scanners offer smart technologies and tools that support you in diagnosing and staging lung cancer:

  • Use our dose-saving technologies also for lung cancer screening protocols
  • Dose efficiency and early detection with our Tin filter technology
  • Obtain highly sensitive and specific information on lung nodules with our second-reader tool Lung CAD
  • Fulfill country-specific guidelines for lung nodules with a diameter ≥ 8 mm or a volume ≥ 300 mm5 when performing CT-guided interventions with our Adaptive 3D Intervention Suite
Lung cancer imaging with ultra-low-dose CT scanners
Lung cancer imaging with PET/MRI
Lung cancer imaging with PET/CT
Diagnosis of lung cancer with bronchoscopy
Diagnosis of lung cancer with surgical biopsy
Diagnosis of lung cancer with laboratory testing systems and tumor markers
Lung cancer workflow with AI-RAD Companion
Lung cancer workflow with syngo Carbon
1/8

Therapy

With the implementation of lung cancer screening protocols for at-risk patients, lung cancer can be detected at an early stage which could dramatically improve chances for survival.10 As a result, there will be an increasing focus on image-guided minimally invasive treatment options with curative intent.

1/7
Imaging02
Radiotherapy01
Software04
Lung cancer imaging for minimally-invasive interventions

3D visualization of lung cancer nodules, airways, and devices to support lung cancer biopsy interventions. System: Cios Spin.

Clinical image courtesy of Roberto Casal, MD, MD Anderson Cancer Center, Texas, USA

Image-guided minimally invasive intervention with C-arm

Whether for image-guided endobronchial interventions, thoracic surgery, or percutaneous lung cancer interventions: Our comprehensive portfolio of imaging solutions for image-guided minimally invasive interventions empowers you to enhance precision and minimize time at risk.

Lung cancer imaging for minimally-invasive interventions
Lung cancer imaging for precise radiotherapy planning
Lung cancer radiotherapy
Lung cancer imaging providing hard- and soft-tissue information during interventions
Lung cancer imaging for planning and guidance for percutaneous needle procedures
Lung cancer imaging with syngo Toolbox
syngo.via RT Imaging Suite makes simulation, image assessment, and contouring easier and better integrated
1/7

 

Monitoring & follow-up

Therapy monitoring and follow-up in lung cancer are key to personalizing patient care. Monitoring tumor response allows for timely adjustment of the chosen therapy. Three challenges have to be met: timely communication, medical data management, and thorough patient engagement.

Explore our portfolio for lung cancer monitoring & follow-up

 

Ultra-low-dose CT scans for lung cancer monitoring and follow-up

Ultra-low-dose CT

Through functional examinations such as tissue perfusion or iodine quantification, our SOMATOM CT scanners enable early assessment of lung tumor response or disease progression.


Tumor marker tests for lung cancer monitoring and follow-up

Tumor marker tests

Tumor marker tests are available on the Atellica® IM Analyzer and ADVIA Centaur® Immunoassay Systems to assess and monitor squamous cell carcinoma in the head, neck, lung and cervix.


Video consultation solution for lung cancer monitoring and follow-up

eHealth Virtual Visit

Secure13 live video consultation that transforms care delivery by enabling timely and precise clinical decision making. Healthcare providers and patients can interact virtually just in minutes14.

Noona mobile app facilitates lung cancer monitoring workflow

Noona

The mobile app enables patients to actively participate during their therapy and follow up. Treatment insights, personalized education, and real-time recording of ePROs foster a collaborative approach to individualizing and optimizing post-treatment care.

Early-stage lung cancer – the road to a cure

Accompany a young female lung cancer patient on her journey through Chang Gung Memorial Hospital, Taiwan, after having received a lung cancer diagnosis. See how early detection and minimally invasive, image-guided thoracoscopic surgery can provide hope.

 

Further insights

 

Stories from the medtech world

Explore the perspectives of pioneers who are seeking new ways to provide better healthcare, including advancements in lung cancer screening, diagnosis, and treatment. 

More information

 

Clinical Specialties Lung Cancer

AI in lung screening and beyond

Download our flyer "AI in lung screening and beyond" and learn how AI can potentially increase the efficiency of lung screening.15

Dowload our whitepaper on PET/CT imaging after abdominal surgery

Case study

Download our case study “PET-CT delineation of implantation metastases along the surgery corridor after abdominal surgery in a patient with NSCLC”.

Enhanced lung cancer imaging with our CT Oncology Engine

CT Oncology Engine

Make confident diagnostic decisions backed by high-end CT image quality. Find out more about our CT Oncology Engine that enhances precision in oncology imaging.

3
Source: IARC / World Health Organization, 2020
5
British Thoracic Society guidelines for pulmonary nodules. https://thorax.bmj.com/content/70/Suppl_2/ii1 (last accessed 14 April 2020)
6
DotGo Workflow for Biograph mMR is still under development and not commercially available yet. Its future availability cannot be ensured.
7
Based on volumetric resolution available in competitive literature for systems greater than 70 cm bore size. Data on file. 
8
The information shown herein refers to a product of 3rd party manufacturer Intuitive and thus are in their regulatory responsibility. Please contact the 3rd party manufacturer for further information and availability.
9
Intuitive Ion Endoluminal System with the Siemens Healthineers NaviLink 3D interface is 510(k) cleared. Currently, it is not for sale outside the U.S. Its future availability cannot be guaranteed.
10
National Lung Screening Trial Research Team. N Engl J Med 2011;365:395-409
12
Image by courtesy of Leopoldina Hospital Schweinfurt, Germany. Rendering not generated with syngo.via
13
Secure Video Chat is security driven design and architecture based on international standards, the communication is fully encrypted, and its technology is state of the art.
14
Prerequisites include: Internet connection to clinical network, DICOM compliance, meeting of minimum hardware requirements, and adherence to local data privacy regulations.
15
P.A. Grenier, A.L. Brun & F.Mellot (2022), The potential role of artificial intelligence in lung cancer screening using low-dose computed tomography. Diagnostics, 2022, 12(20), 2435